Mubritinib (Tak-165) CAS 366017-09-6

Pemetrexed disodium hepthydrate CAS 357166-29-1
14/12/2018
Saracatinib CAS 379231-04-6
14/12/2018
Show all

Model: MOS 366017-09-6
Place of Origin: Shandong,China (Mainland)
Brand: MOSINTER
Formula: C25H23F3N4O2
Mol. mass: 468.47 g/mol
Boiling point: 620.9°C at 760 mmHg
Density: 1.25g/cm3
Flash(ing) point: 329.3°C
Vapour pressure: 2.43E-15mmHg at 25°C

Mubritinib (Tak-165) (CAS: 366017-09-6)

Item Index
Molecular Formula C25H23F3N4O2
Molecular Weight 468.47
Specification CP/USP/EP
Content 98%min

Mubritinib (Tak-165)  is a potent Neu (HER2) and Cdc2 p34 inhibitor with IC50 of 6 nM and 0.2μM, respectively. TAK 165 also inhibits p33cdk2 and p33cdk5. TAK 165 displays > 4000-fold selectivity over EGFR, FGFR, PDGFR, JAK1 and Src. TAK 165 exhibits potent antiproliferative effects in Neu-overexpressing cancer cell lines (IC50 = 5 nM in BT474 breast cancer cells) and significantly inhibits bladder, breast and prostate cancer xenograft growth. 

Basic Information

Mubritinib (TAK-165) is a protein kinase inhibitor which was under development by Takeda for the treatment of cancer. It completed phase Iclinical trials but appears to have been discontinued, as no new information on the drug has surfaced since December 2008.

Reviews

There are no reviews yet.

Be the first to review “Mubritinib (Tak-165) CAS 366017-09-6”